Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 32% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 25% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 13201.32 | 2639 / 2642 | 100% | 78.71 | 703 / 705 |
thymus | 58% | 743.12 | 378 / 653 | 88% | 13.06 | 533 / 605 |
adrenal gland | 24% | 392.36 | 61 / 258 | 79% | 40.55 | 181 / 230 |
uterus | 46% | 576.86 | 79 / 170 | 47% | 8.38 | 217 / 459 |
breast | 12% | 171.61 | 57 / 459 | 75% | 17.43 | 833 / 1118 |
ovary | 17% | 203.53 | 31 / 180 | 53% | 5.94 | 230 / 430 |
heart | 56% | 739.63 | 479 / 861 | 0% | 0 | 0 / 0 |
prostate | 42% | 467.07 | 102 / 245 | 12% | 0.77 | 59 / 502 |
skin | 2% | 18.30 | 37 / 1809 | 51% | 5.78 | 239 / 472 |
bladder | 19% | 145.10 | 4 / 21 | 31% | 3.32 | 155 / 504 |
esophagus | 13% | 148.48 | 195 / 1445 | 28% | 2.68 | 52 / 183 |
tonsil | 0% | 0 | 0 / 0 | 38% | 4.23 | 17 / 45 |
pancreas | 0% | 0 | 0 / 328 | 37% | 2.67 | 66 / 178 |
lung | 4% | 39.12 | 24 / 578 | 31% | 2.90 | 362 / 1155 |
intestine | 22% | 211.36 | 208 / 966 | 10% | 0.85 | 51 / 527 |
kidney | 6% | 47.87 | 5 / 89 | 21% | 2.25 | 190 / 901 |
eye | 0% | 0 | 0 / 0 | 23% | 1.61 | 18 / 80 |
stomach | 9% | 83.91 | 31 / 359 | 12% | 1.25 | 34 / 286 |
adipose | 19% | 198.37 | 230 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 8% | 77.46 | 105 / 1335 | 0% | 0 | 0 / 0 |
spleen | 6% | 55.18 | 14 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 3% | 0.42 | 11 / 406 |
muscle | 2% | 23.33 | 15 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 10.48 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0007422 | Biological process | peripheral nervous system development |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ADGRB2 |
Protein name | Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2) Adhesion G protein-coupled receptor B2 |
Synonyms | BAI2 |
Description | FUNCTION: Orphan G-protein coupled receptor involved in cell adhesion and probably in cell-cell interactions. Activates NFAT-signaling pathway, a transcription factor, via the G-protein GNAZ . Involved in angiogenesis inhibition (By similarity). . |
Accessions | O60241 ENST00000420125.5 A2A3C1 A2A3C6 A2A3C3 E9PND1 ENST00000398542.5 ENST00000398556.7 A2A3C2 ENST00000373658.8 [O60241-1] A2A3C4 ENST00000398538.5 ENST00000527361.5 [O60241-4] ENST00000373655.6 [O60241-2] ENST00000398547.5 ENST00000533175.1 |